These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24749925)

  • 1. Cardiac resynchronization therapy: the state of the art.
    Madias C; Trohman RG
    Expert Rev Cardiovasc Ther; 2014 May; 12(5):573-87. PubMed ID: 24749925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study.
    Auricchio A; Delnoy PP; Butter C; Brachmann J; Van Erven L; Spitzer S; Moccetti T; Seifert M; Markou T; Laszo K; Regoli F;
    Europace; 2014 May; 16(5):681-8. PubMed ID: 24497573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT).
    Birnie DH; Ha A; Higginson L; Sidhu K; Green M; Philippon F; Thibault B; Wells G; Tang A
    Circ Heart Fail; 2013 Nov; 6(6):1190-8. PubMed ID: 23995437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.
    Freeman JV; Masoudi FA
    Heart Fail Clin; 2013 Jan; 9(1):59-77. PubMed ID: 23168318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy: state of the art 2013.
    Yu CM; Hayes DL
    Eur Heart J; 2013 May; 34(19):1396-403. PubMed ID: 23355652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantation of left ventricular epicardial leads in cardiosurgical patients with impaired cardiac function--a worthwhile procedure in concomitant surgical interventions?
    Mellert F; Schneider C; Esmailzadeh B; Balta O; Haushofer M; Schiller W; Preusse CJ; Welz A
    Thorac Cardiovasc Surg; 2012 Feb; 60(1):64-9. PubMed ID: 21425053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization therapy update: evolving indications, expanding benefit?
    Butcher C; Mareev Y; Markides V; Mason M; Wong T; Cleland JG
    Curr Cardiol Rep; 2015 Oct; 17(10):90. PubMed ID: 26298308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure.
    Sims DB; Mignatti A; Colombo PC; Uriel N; Garcia LI; Ehlert FA; Jorde UP
    Europace; 2011 Oct; 13(10):1459-63. PubMed ID: 21551475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume.
    Bogale N; Priori S; Gitt A; Alings M; Linde C; Dickstein K;
    Europace; 2011 Oct; 13(10):1445-53. PubMed ID: 21712274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronisation therapy in patients with chronic heart failure.
    Lalani GG; Birgersdotter-Green U
    Heart; 2015 Jul; 101(13):1008-14. PubMed ID: 25882504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy: current trends and future directions.
    Jacob S; Bharadwaj AS; Panaich SS; Mathew A; Afonso L
    Minerva Cardioangiol; 2010 Dec; 58(6):717-29. PubMed ID: 21135811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronization therapy: expanding clinical indications and refining patient selection.
    Nery PB; Keren A; Birnie DH
    Curr Opin Cardiol; 2012 Mar; 27(2):137-42. PubMed ID: 22233979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy in mildly symptomatic heart failure: the earlier the better.
    Balmain S; McDonald MA
    Expert Rev Cardiovasc Ther; 2011 Sep; 9(9):1147-53. PubMed ID: 21932957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why We Have to Use Cardiac Resynchronization Therapy-Pacemaker More.
    Daubert JC; Martins R; Leclercq C
    Heart Fail Clin; 2017 Jan; 13(1):153-164. PubMed ID: 27886920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.